PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
NASDAQ · Healthcare · Medical - Devices · US
$2.90
+2.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.14x
- Price / sales
- 5.66x
- Price / cash flow
- -5.54x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 8.61x
- EV / EBITDA
- -12.57x
- EV / EBIT
- -8.43x
- Market cap
- $901.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026